Sweet Tooth Gene Linked to Less Body Fat

Summary: Researchers report people with the ‘sweet tooth’, FGF21 genetic mutation tend to have less body fat. However, the genetic mutation is also linked to slightly elevated blood pressure.

Source: University of Copenhagen.

People with a gene variation of FGF21 have a predisposition to less body fat than others, new research conducted at the University of Copenhagen, among others, shows.

It comes as a bit of a surprise to the researchers, who last year discovered that precisely this genetic variation could be one of the reasons why some people have a particular craving for sweet things. People with this variation eat more sugar than others.

‘It sort of contradicts common intuition that people who eat more sugar should have less body fat. But it is important to remember that we are only studying this specific genetic variation and trying to find connections to the rest of the body. This is just a small piece of the puzzle describing the connection between diet and sugar intake and the risk of obesity and diabetes’, says one of the researchers behind the study, Associate Professor Niels Grarup from the Novo Nordisk Foundation Center for Basic Metabolic Research.

Higher Blood Pressure and More ‘Apple Shape’

But the effects associated with the genetic variation are not all positive, the new study shows. The genetic variation is connected with slightly increased blood pressure and more fat around the waist than the hips – that is, more ‘apple shape’.

The study is an international collaboration headed by researchers at the University of Exeter Medical School and has just been published in the scientific journal Cell Reports.

The researchers’ conclusions are based on large amounts of data. They have studied health information from more than 450,000 individuals who have allowed their data to be recorded in the UK Biobank. It includes blood samples, questionnaires on diet and genetic data, among other things.

sweets
This new knowledge about people with a ‘genetic sweet tooth’ is mainly important in connection with the development of drugs and future research. NeuroscienceNews.com image is adapted from the University of Copehnagen news release.

‘Now that so many people are involved in the study, it gives our conclusions a certain robustness. Even though the difference in the amount of body fat or blood pressure level is only minor depending on whether or not the person has this genetic variation or not, we are very confident that the results are accurate. Around 20 per cent of the European population has this genetic predisposition’, says Niels Grarup.

Potential Drug Target

This new knowledge about people with a ‘genetic sweet tooth’ is mainly important in connection with the development of drugs and future research. Because researchers are currently trying to determine whether it is possible to target or replace FGF21 using drugs in order to treat for obesity and diabetes.

‘Due to its connection with sugar, FGF21 constitutes a potential target in the treatment of for example obesity and diabetes. This research helps us to understand the underlying mechanisms of the hormone and to predict its effects and side effects’, says Niels Grarup.

About this neuroscience research article

Funding: The study is funded by the European Research Council (ERC), the National Institute of Health (NIH) and the Novo Nordisk Foundation, among others.

Source: University of Copenhagen
Publisher: Organized by NeuroscienceNews.com.
Image Source: NeuroscienceNews.com image is adapted from the University of Copehnagen news release.
Original Research: Open access research for “A Common Allele in FGF21 Associated with Sugar Intake Is Associated with Body Shape, Lower Total Body-Fat Percentage, and Higher Blood Pressure” by Timothy M. Frayling, Robin N. Beaumont, Samuel E. Jones, Hanieh Yaghootkar, Marcus A. Tuke, Katherine S. Ruth, Francesco Casanova, Ben West, Jonathan Locke, Seth Sharp, Yingjie Ji, William Thompson, Jamie Harrison, Amy S. Etheridge, Paul J. Gallins, Dereje Jima, Fred Wright, Yihui Zhou, Federico Innocenti, Cecilia M. Lindgren, Niels Grarup, Anna Murray, Rachel M. Freathy, Michael N. Weedon, Jessica Tyrrell, and Andrew R. Wood in Cell Reports. Published April 10 2018.
doi:10.1016/j.celrep.2018.03.070

Cite This NeuroscienceNews.com Article

[cbtabs][cbtab title=”MLA”]University of Copenhagen “Sweet Tooth Gene Linked to Less Body Fat.” NeuroscienceNews. NeuroscienceNews, 14 April 2018.
<https://neurosciencenews.com/sweet-tooth-gene-body-fat-8786/>.[/cbtab][cbtab title=”APA”]University of Copenhagen (2018, April 14). Sweet Tooth Gene Linked to Less Body Fat. NeuroscienceNews. Retrieved April 14, 2018 from https://neurosciencenews.com/sweet-tooth-gene-body-fat-8786/[/cbtab][cbtab title=”Chicago”]University of Copenhagen “Sweet Tooth Gene Linked to Less Body Fat.” https://neurosciencenews.com/sweet-tooth-gene-body-fat-8786/ (accessed April 14, 2018).[/cbtab][/cbtabs]


Abstract

A Common Allele in FGF21 Associated with Sugar Intake Is Associated with Body Shape, Lower Total Body-Fat Percentage, and Higher Blood Pressure

Highlights
•A human allele in FGF21 is associated with higher alcohol as well as sugar intake
•Phenotypes associated with this allele likely mimic those of lower FGF21 function
•The human allele in FGF21 is associated with lower total body-fat percentage
•The human allele in FGF21 is associated with higher blood pressure and waist-hip ratio

Summary
Fibroblast growth factor 21 (FGF21) is a hormone that has insulin-sensitizing properties. Some trials of FGF21 analogs show weight loss and lipid-lowering effects. Recent studies have shown that a common allele in the FGF21 gene alters the balance of macronutrients consumed, but there was little evidence of an effect on metabolic traits. We studied a common FGF21 allele (A:rs838133) in 451,099 people from the UK Biobank study, aiming to use the human allele to inform potential adverse and beneficial effects of targeting FGF21. We replicated the association between the A allele and higher percentage carbohydrate intake. We then showed that this allele is more strongly associated with higher blood pressure and waist-hip ratio, despite an association with lower total body-fat percentage, than it is with BMI or type 2 diabetes. These human phenotypes of variation in the FGF21 gene will inform research into FGF21’s mechanisms and therapeutic potential.

Feel free to share this University of Copenhagen.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.